Neoteryx provides microsampling devices to fianostics for COVID-19 antibody tests in austria

Within an award-winning study Dr. Pia Gattringer at the medical university of vienna found out that about 20% of persons recovered from an SARS-CoV-2 infection

Researchers identified changes to the brain stem and frontal lobe in patients months after COVID-19 infectionThe affected brain regions are linked with fatigue, insomnia, anxiety,

The INOOlab™ concept is the combination of our highly sensitive FluoBolt™ fluorescence enhancement technology with the innovative dry blood collection method of our partner Neoteryx

A small study (n<20) shows a significant increase of antibodies after every boost. The study also shows the rapid decrease of antibody concentrations after each

In a study including > 1000 participants a significant waning of antibody levels was observed following vaccination. The rate of antibody waning was not affected

Fianostics is awarded the Lower Austrian Innovation PriceThe highly sensitive FluoBolt™-technology for the first time allows the simultaneous quantitative determination of anti S1-RBD and anti